Meeting
2021 Genitourinary Cancers Symposium
Genomic analysis for active surveillance to predict upstaging after prostatectomy.
Authors
Andrea Quinn
Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA
Andrea Quinn , Erica Mann , Costas D. Lallas , James Ryan Mark , Thenappan Chandrasekar , Edouard John Trabulsi , Leonard G. Gomella , Mark Jonathan Mann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Prostate Cancer - Localized Disease
Track
Prostate Cancer - Localized
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 39, 2021 (suppl 6; abstr 258)
DOI
10.1200/JCO.2021.39.6_suppl.258
Abstract #
258
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2016 Genitourinary Cancers Symposium
Change in a 17-gene genomic prostate score over time in men with low- and intermediate-risk prostate cancer managed with active surveillance.
First Author: Michael S. Leapman
Poster
2019 Genitourinary Cancers Symposium
Cribriform pattern, Genomic Prostate Score, and adverse pathology at radical prostatectomy in a cohort of prostate cancer patients initially on active surveillance.
First Author: Kyle Brian Zuniga
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2015 Genitourinary Cancers Symposium
Association between a 17-gene genomic prostate score and multiparametric prostate MRI in men with low- and intermediate-risk prostate cancer (PCa).
First Author: Michael S. Leapman